OQROGet OQRO Pro
Insider trade

Entrada Therapeutics (TRDA)CFO sold ~$19K

Kory James Wentworth, CFO at Entrada Therapeutics, sold ~$19K of Entrada Therapeutics shares.

~$19K
Approx. value · 1,784 sh @ $10.67
110K
Holds after · shares reported
Traded
Mar 17, 2025
Filed
Mar 19, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 13, 2024InsiderDirector purchased ~$367K of TRDA shares in the open market
  2. May 14, 2024InsiderDirector purchased ~$365K of TRDA shares in the open market
  3. Mar 17, 2025 · this disclosureInsiderCFO sold ~$19K of TRDA shares in the open market

What came next

  1. Jun 27, 2025Insider · 2 peopleInsiders: 4 sales (~$1.0M)
  2. Jun 30, 2025Insider · 2 peopleInsiders: 4 sales (~$341K)
  3. Jul 1, 2025Insider · 2 peopleInsiders: 4 sales (~$356K)
  4. Jul 9, 2025Insider · 2 peopleInsiders: 4 sales (~$405K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Entrada Therapeutics

For Entrada Therapeutics, OQRO holds 33 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TRDA page.

Other recent filings by Kory James Wentworth, Chief Financial Officer

The full history of Kory James Wentworth, Chief Financial Officer is on the profile page.

How this filing works

Other disclosures at Entrada Therapeutics

Everything OQRO holds on this company is on its TRDA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data